Rockwell Medical (NASDAQ:RMTI - Get Free Report) was downgraded by research analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued on Friday.
Several other equities research analysts also recently issued reports on the stock. HC Wainwright lowered their price objective on shares of Rockwell Medical from $9.00 to $7.00 and set a "buy" rating for the company in a research report on Monday, November 25th. Rodman & Renshaw assumed coverage on shares of Rockwell Medical in a research note on Thursday, November 14th. They issued a "buy" rating and a $5.00 target price for the company. Finally, RODMAN&RENSHAW raised Rockwell Medical to a "strong-buy" rating in a research note on Thursday, November 14th.
Check Out Our Latest Stock Analysis on RMTI
Rockwell Medical Stock Up 1.5 %
Shares of RMTI traded up $0.03 on Friday, hitting $2.08. The company's stock had a trading volume of 479,928 shares, compared to its average volume of 398,320. The firm's fifty day moving average price is $2.92 and its 200-day moving average price is $2.69. Rockwell Medical has a fifty-two week low of $1.16 and a fifty-two week high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $67.22 million, a price-to-earnings ratio of -41.60 and a beta of 1.38.
Institutional Trading of Rockwell Medical
Institutional investors have recently made changes to their positions in the business. Concurrent Investment Advisors LLC bought a new position in Rockwell Medical in the third quarter valued at $40,000. Verus Capital Partners LLC bought a new position in shares of Rockwell Medical in the 3rd quarter valued at about $51,000. Barclays PLC bought a new position in shares of Rockwell Medical in the 3rd quarter valued at about $90,000. Beacon Financial Advisory LLC acquired a new stake in shares of Rockwell Medical in the third quarter valued at about $98,000. Finally, XTX Topco Ltd raised its holdings in Rockwell Medical by 45.7% during the third quarter. XTX Topco Ltd now owns 28,455 shares of the company's stock worth $113,000 after acquiring an additional 8,922 shares in the last quarter. Institutional investors own 23.31% of the company's stock.
Rockwell Medical Company Profile
(
Get Free Report)
Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.
Recommended Stories
Before you consider Rockwell Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rockwell Medical wasn't on the list.
While Rockwell Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
